Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer.

Francesco CucciaLuca NicosiaRosario MazzolaVanessa FigliaNiccolò Giaj-LevraFrancesco RicchettiMichele RigoClaudio VitaleStefanie CorradiniRuggero RuggieriFilippo Alongi

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2020)

Despite of the heterogeneity of the sample, linac-based SBRT as a salvage treatment in previously irradiated locally recurrent PC patients seems to be a safe and feasible treatment option. Long-term data are pending.

Keyphrases

prostate cancer
radiation therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
single cell
electronic health record
prognostic factors
radical prostatectomy
combination therapy
replacement therapy